About us
Nucleoptis International owns and acquires stakes in companies primarily within the med tech sector with special focus on eye care.
Its objective is to align the interests of owners, management and employees, guaranteeing the long term success of its businesses.
Nucleoptis provides the umbrella organisation for formerly independent companies. Its philosophy is to respect the independence of its affiliates, benefit from the agility vis-a-vis its customers and promote best practice within the company.
Team
Nucleoptis International, established in 2021 in Switzerland, is owned and managed by the two founders, Roland Bruhin and Reto Senn.
Their experiences stem from leading positions held in various health care companies in Asia and Europe as well as from various current executive and non-executive board mandates.